These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4256145)

  • 1. Phase I and II studies of 2'-deoxy-5-(trifluoromethyl)-uridine (NSC-75520).
    Ansfield FJ; Ramirez G
    Cancer Chemother Rep; 1971 Apr; 55(2):205-8. PubMed ID: 4256145
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
    Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of 5'-deoxy-5-fluorouridine in malignant tumors under cooperative study (phase II study)].
    Murakami M; Ota K; Yasue M; Hoshino A; Kamiya O; Kinoshita T; Yamada M; Hiraiwa K; Hachisuka K; Yamaguchi A
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1026-35. PubMed ID: 2944975
    [No Abstract]   [Full Text] [Related]  

  • 6. Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
    Slack NM; Jones R
    Cancer Chemother Rep; 1970 Feb; 54(1):53-63. PubMed ID: 4945998
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
    [No Abstract]   [Full Text] [Related]  

  • 8. 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.
    Fink DJ; Foye LV
    Cancer Chemother Rep; 1970 Feb; 54(1):31-4. PubMed ID: 4945996
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia; 1986 Apr; 5(2):134-9. PubMed ID: 2871945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).
    Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB
    Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
    Sullivan RD; Miller E
    Cancer Res; 1965 Aug; 25(7):1025-33. PubMed ID: 4284747
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1969 Oct; 53(5):283-5. PubMed ID: 4247211
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
    Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude mice.
    Howell SB; Jenkins RS; Streifel J
    Cancer Res; 1979 Oct; 39(10):3875-80. PubMed ID: 476623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of VM-26 in adult malignancies.
    Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
    Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of 5'-deoxy-5-fluorouridine on human gastrointestinal and breast cancers xenografted to nude mice].
    Fujita F; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1635-43. PubMed ID: 6236751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.